The Bharat Serums and Vaccines (BSV), a biopharmaceutical company in India, inked an exclusive distribution agreement with MediWound (NASDAQ: MDWD) in December 2022 to introduce NexoBrid, a groundbreaking treatment for severe burns, in the Indian market.
Mumbai (Maharashtra) [India], August 29 (ANI/PRNewswire): Realizing the financial burden in IVF treatment as a concern for aspiring parents, Bharat Serums and Vaccines (BSV) launched a program BSVwithU to support couples to realize their dream of parenthood. Under this initiative, BSVwithU f
Hyderabad (Telangana) [India], April 12 (ANI): Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would invest Rs 200 crore in the development of injectable and vaccine manufacturing facility at Genome Valley, India's first organised cluster for Life Sciences
Mumbai (Maharashtra) [India], March 25 (ANI/BusinessWire India): Veeva Systems (NYSE: VEEV) today announced one of India's fastest-growing biopharma companies, Bharat Serums and Vaccines Limited (BSV), is standardizing on Veeva Vault PromoMats to accelerate its end-to-end content lifecycle f
New Delhi [India], July 27 (ANI): The unprecedented COVID-19 crisis has emerged as a huge challenge for couples seeking In Vitro Fertilisation (IVF) treatment in India, experts said.